Skip to content
Dose Brief
Menu

Briefs · 40 providers

Every provider in the ranking, scored

Each GLP-1 telehealth provider we track, graded on the Brief Score — price stability, supply reliability, transparency and access.

Showing 1–40 of 546. Most recent verification in the ranking: .

Grade A

The strongest on price stability and supply.

Grade B

Solid providers with a trade-off worth reading first.

Brief Scores are our editorial judgment per the methodology; facts reflect each provider's public disclosures at last check. A commission never changes a score, and it never softens what we write about a provider. What it does move is position: this index runs in ranking order, and providers we have a commercial relationship with sit ahead of providers we do not. Weigh the write-up, not the slot — see our disclosure. Not medical advice.

The desk's No. 1 · 94/100

CoreAge Rx

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Semaglutide
$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published
Tirzepatide
$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published
Visit CoreAge Rx ↗
Full brief →Ad disclosure — we may earn a commission.

Shopping on price?

See every provider with its price direction and the note behind it.

Open the ranking →